U.S. Vape Firms Urge Federal Court to Block North Carolina’s New Rules, Citing Unconstitutionality and Business Threats

Jul.16.2025
U.S. Vape Firms Urge Federal Court to Block North Carolina’s New Rules, Citing Unconstitutionality and Business Threats
Vape groups asked the U.S. Fourth Circuit to block a North Carolina law they say, pushed by Reynolds American, threatens quit-smoking products and violates federal authority under the Constitution’s Supremacy Clause.

Key points:

 

·The e-cigarette industry is urging the Fourth Circuit Court of Appeals to block a sales ban on e-cigarettes in North Carolina. 

 

·The ban was pushed by Reynolds American Inc. and aims to combat e-cigarette products that help people quit smoking. 

 

·The industry argues that the law infringes on federal power and violates the supremacy clause of the U.S. Constitution. 

 

·The court had previously denied the industry's request for an injunction, but the industry is now appealing.


【2Firsts News Flash】According to a report by Law360 on July 14, e-cigarette stakeholders in the United States are urging the Fourth Circuit Court of Appeals to temporarily block North Carolina officials from enforcing a law that could prevent the sale of multiple e-cigarette products in the state. They claim that the law, which they say is supported by tobacco giant Reynolds American Inc., targets products that help people quit smoking.

 

The American Vaping Association (VTA) and its co-plaintiffs argue that the law (Senate Bill 31 of 2024) gives state tax officials the authority to fine e-cigarette retailers, wholesalers, and manufacturers who do not have authorization from the US Food and Drug Administration (FDA). However, states cannot enforce FDA regulations because it infringes on federal power, violating the supremacy clause of the US Constitution, stakeholders in the e-cigarette industry claim in a filing submitted to the Fourth Circuit Court of Appeals.

 

The plaintiffs in the e-cigarette industry are asking the court to block the state law from taking effect so they can challenge it in federal court. They believe that their arguments may likely succeed on the merits and that their businesses will suffer if the law goes into effect, so they argue that an injunction is appropriate.

 

“The plaintiff sells mostly electronic nicotine delivery systems in their professional e-cigarette store that have not yet received FDA market authorization and therefore do not qualify for inclusion in the [North Carolina] directory. Without the sales revenue from these products, the appellant would face the risk of business closure, employee layoffs, and potential bankruptcy.”

 

Motion was made during the meeting.

 

The plaintiffs in the e-cigarette industry claim that this law gives the state tax department the power to fine retailers and manufacturers of e-cigarettes who sell products not authorized by the FDA. According to court records, retailers selling these unapproved products could face fines up to $5,000, as well as other penalties such as temporary suspension of their license, complete revocation of their license, and confiscation of products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria has released its full-year 2025 results, reporting full-year net revenues of $23.279 billion, down 3.1% year over year. Domestic cigarette shipment volume fell 10% for the year. on! nicotine pouches reached a 7.7% share of the U.S. oral tobacco category in the fourth quarter. NJOY posted $21 million in net revenues in Q4, while full-year net revenues were negative $13 million (mainly due to returns and related factors).
Jan.30 by 2FIRSTS.ai
South Korea Postal Service Launches Heated Tobacco Device Recycling Program Through Nationwide Post Offices and Mailboxes
South Korea Postal Service Launches Heated Tobacco Device Recycling Program Through Nationwide Post Offices and Mailboxes
Korean postal system launches nationwide heated tobacco device recycling through post offices and mailboxes, aiming to increase recycling rates.
Feb.10 by 2FIRSTS.ai
Kumulus Vape launches Labster production unit for e-liquids and DIY concentrates
Kumulus Vape launches Labster production unit for e-liquids and DIY concentrates
Kumulus Vape has launched Labster, a 700 sq m production unit in the Lyon Metropolis near the group’s headquarters, for e-liquids and DIY concentrates. The site is equipped with automated lines supplied by CDA (Constructions d’Automatismes) to carry out bottling and labeling. Its theoretical capacity is described as several million bottles per year in 10–100 ml formats, and it is already operational.
Feb.06 by 2FIRSTS.ai
The Volume Illusion: Measuring the Future of Nicotine with the Tools of the Past
The Volume Illusion: Measuring the Future of Nicotine with the Tools of the Past
As next-generation nicotine products become economically central rather than marginal, traditional volume-based metrics are increasingly unable to explain consumption, risk, and value. Units designed for a cigarette-based economy struggle to describe systems defined by delivery speed, pharmacokinetics, and adaptive user behavior. Drawing on financial reporting, regulation, and nicotine science, a fundamental question: can the future of nicotine still be measured using the tools of its past?
Feb.09 by Alan Zhao | 2Firsts Perspectives
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24